Colorectal polyp
Conditions
Interventions
Group A:During the first colonoscopy, an oral solution of sodium potassium magnesium sulfate was taken as an intestinal preparation agent. Polyethylene glycol electrolyte powder was taken orally as an
Group B:During the first colonoscopy, polyethylene glycol electrolyte powder was taken orally as an intestinal preparation agent. An oral solution of magnesium sodium potassium sulfate was taken as an
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Endoscopic resection of colorectal polyps was performed in each research center; (2) Voluntarily participate in the test and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Allergic to the investigational drug and its ingredients; (2) Participating in other clinical trials or receiving special drug treatment; (3) Known or suspected gastrointestinal bleeding, gastrointestinal perforation, or gastrointestinal obstruction; (4) Ascites, suspected electrolyte abnormalities, or uncorrected dehydration; (5) Presence or high suspicion of colorectal cancer, inflammatory bowel disease, toxic colitis, or toxic megacolon; (6) Previous colorectal resection; (7) Known severe renal insufficiency, severe liver insufficiency, or severe congestive heart failure; (8) Patients with serious cardiovascular and cerebrovascular, metabolic, endocrine and other diseases cannot tolerate examination; (9) Pregnant or lactating women; (10) Constipation (frequency of defecation <3 times per week, difficult and laborious defecation, dry stool, small amount).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qualification rate of intestinal preparation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Security ;Acceptability;obedience; | — |
Countries
China
Contacts
Public ContactBing Hu
West China Hospital of Sichuan University
Outcome results
None listed